Stockreport

Aquestive Therapeutics: Looking For The PDUFA Run-Up [Seeking Alpha]

Aquestive Therapeutics, Inc.  (AQST) 
Last aquestive therapeutics, inc. earnings: 3/11 04:30 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.aquestive.com/investor-relations
PDF Anaphylm's needle-free, oral epinephrine alternative could capture 8-12% of the $2.7B U.S. auto-injector market by 2033. AQST's technical setup, undervaluation, and s [Read more]